{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:02:13Z","timestamp":1779778933157,"version":"3.53.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,25]]},"DOI":"10.7759\/cureus.109656","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:02:46Z","timestamp":1779775366000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Refractory Hypercalcemia as the Initial Presentation of Sarcoidosis With Acute Kidney Injury Requiring Hemodialysis"],"prefix":"10.7759","author":[{"given":"Shalima","family":"Sabu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishnu","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia: a review","volume":"328","author":"Walker MD","year":"2022","unstructured":"Walker MD, Shane E. Hypercalcemia: a review. JAMA. 2022, 328:1624-36. 10.1001\/jama.2022.18331","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.935821","article-title":"A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia","volume":"28","author":"Tonon CR","year":"2022","unstructured":"Tonon CR, Silva TA, Pereira FW, et al.. A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia. Med Sci Monit. 2022, 28:e935821. 10.12659\/MSM.935821","journal-title":"Med Sci Monit"},{"key":"ref3","article-title":"Disorders of the parathyroid gland and calcium homeostasis","author":"Potts JT Jr","year":"2022","unstructured":"Potts JT Jr,J\u00fcppner H. Disorders of the parathyroid gland and calcium homeostasis. Harrison's Principles of Internal Medicine. Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J (ed): McGraw-Hill Education, New York; 2022. 21e."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve P","year":"2021","unstructured":"S\u00e8ve P, Pacheco Y, Durupt F, et al.. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells. 2021, 10:766. 10.3390\/cells10040766","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1479973119878713","article-title":"Sarcoidosis and calcium homeostasis disturbances-do we know where we stand?","volume":"16","author":"Gwadera \u0141","year":"2019","unstructured":"Gwadera \u0141, Bia\u0142as AJ, Iwa\u0144ski MA, G\u00f3rski P, Piotrowski WJ. Sarcoidosis and calcium homeostasis disturbances-do we know where we stand?. Chron Respir Dis. 2019, 16:10.1177\/1479973119878713","journal-title":"Chron Respir Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00244-z","article-title":"Sarcoidosis: molecular mechanisms and therapeutic strategies","volume":"6","author":"Xu D","year":"2025","unstructured":"Xu D, Tao X, Fan Y, Teng Y. Sarcoidosis: molecular mechanisms and therapeutic strategies. Mol Biomed. 2025, 6:6. 10.1186\/s43556-025-00244-z","journal-title":"Mol Biomed"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.100591","article-title":"Renal sarcoidosis presenting as acute kidney injury with persistent hypercalcemia in the absence of respiratory symptoms: a report of a rare case","volume":"18","author":"Khan MJ","year":"2026","unstructured":"Khan MJ, Akbar MA, Ahmad T, Zahid A, Faisal F. Renal sarcoidosis presenting as acute kidney injury with persistent hypercalcemia in the absence of respiratory symptoms: a report of a rare case. Cureus. 2026, 18:e100591. 10.7759\/cureus.100591","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.105121","article-title":"Severe hypercalcemia and acute kidney injury as initial manifestations of multisystem sarcoidosis in an adolescent with type 1 diabetes: a case report","volume":"18","author":"Wang Y","year":"2026","unstructured":"Wang Y, Ott M, Ekdahl R, Costa A. Severe hypercalcemia and acute kidney injury as initial manifestations of multisystem sarcoidosis in an adolescent with type 1 diabetes: a case report. Cureus. 2026, 18:e105121. 10.7759\/cureus.105121","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac621","article-title":"Treatment of hypercalcemia of malignancy in adults: an endocrine society clinical practice guideline","volume":"108","author":"El-Hajj Fuleihan G","year":"2023","unstructured":"El-Hajj Fuleihan G, Clines GA, Hu MI, et al.. Treatment of hypercalcemia of malignancy in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2023, 108:507-28. 10.1210\/clinem\/dgac621","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi K","year":"2011","unstructured":"Fizazi K, Carducci M, Smith M, et al.. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet. 2011, 377:813-22. 10.1016\/S0140-6736(10)62344-6","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06998-y","article-title":"Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report","volume":"35","author":"Fujita N","year":"2024","unstructured":"Fujita N, Ono Y, Hashimoto K, et al.. Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report. Osteoporos Int. 2024, 35:733-6. 10.1007\/s00198-023-06998-y","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman RP","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P, et al.. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021, 58:2004079. 10.1183\/13993003.04079-2020","journal-title":"Eur Respir J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/491018-severe-refractory-hypercalcemia-as-the-initial-presentation-of-sarcoidosis-with-acute-kidney-injury-requiring-hemodialysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:02:47Z","timestamp":1779775367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/491018-severe-refractory-hypercalcemia-as-the-initial-presentation-of-sarcoidosis-with-acute-kidney-injury-requiring-hemodialysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.109656","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}